Skip to content

Honest Open Proud for Psychotic and Bipolar Disorder in Norway

Evaluation of a Norwegian Adaptation of the Honest Open Proud Program for Adults With Psychotic and Bipolar Disorders in an Outpatient Setting

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06384755
Acronym
HOP-NOR
Enrollment
40
Registered
2024-04-25
Start date
2024-04-20
Completion date
2026-12-31
Last updated
2024-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder, Disclosure, Psychotic Disorders

Keywords

Honest Open Proud program, Psychotic and Bipolar disorders

Brief summary

The purpose of this pilot study is to evaluate the feasibility, acceptability and efficacy of a Norwegian adaptation of the group-based intervention 'Honest Open Proud' among adults with psychotic and bipolar disorders in an outpatient setting.

Detailed description

Because people with mental illness experience both public and personal stigma, which is related to lower levels of recovery and wellbeing, it is common to struggle with decisions regarding potential disclosure of mental health difficulties or diagnoses. There are pros and cons with both disclosure and secrecy. Disclosure can lead to social support, followed by improved mental health and reduced public stigma, but also stigmatization and social exclusion. Secrecy can prevent stigmatization but may also lead to social isolation and thus poorer mental health and increased public stigma. Therefore, people with mental illness need help to make strategic decisions about whether, and if so, to whom, when and how they wish to disclose their mental health problems. As contact with other people with mental health difficulties is crucial to anti-stigma interventions, people with mental illness could benefit from meeting peers, especially as role models. This suggests that peer facilitators could be an important feature in a program aiming to help people with mental illness handle stigma and challenges related to disclosure. The Honest Open Proud (HOP) program was developed for this purpose. Because people with psychotic and bipolar disorders experience particularly high levels of both public and personal stigma, which negatively impacts their recovery rates, they may be especially in need of the HOP program. The investigators aim to evaluate whether a Norwegian adaptation of the HOP group program, which is facilitated by peers, is feasible and acceptable for people with psychotic and bipolar disorders in an outpatient setting. Moreover, whether it helps them handle stigma and disclosure related decisions. The investigators propose a pilot randomized controlled trial, comparing an intervention group receiving a 6-week Norwegian adaptation of the HOP program to a waiting list control group. Both groups receive treatment as usual. The main research question is whether this intervention is feasible and acceptable. However, efficacy measures tapping change in stigma and disclosure distress, as well as recovery and wellbeing, from before to after the intervention, were included. The aim is to find what effect sizes can be expected in future larger studies in Norway, rather than to find significant differences in effect sizes.

Interventions

BEHAVIORALHonest Open Proud program

The HOP program involves peer facilitated sessions, in which different stigma and disclosure related topics are introduced to the group, relevant tasks are completed individually, followed by group or two-and-two discussions related to the following topics: week 1 = pros and cons with disclosure, week 2 = different ways of disclosing, week 3 = formulating individual decisions of disclosure, week 6 = evaluating disclosure or non-disclosure in practice.

Sponsors

University of Oslo
CollaboratorOTHER
Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed current psychotic (F 20) or bipolar disorder (F 30) according to International Classification of Diseases 10th Revision (ICD-10) * Age 18 to 65 * Ability to provide written informed consent. * Fluent in Norwegian (needed for self-report measures) * Experience difficulties with stigma and disclosure regarding mental illness.

Exclusion criteria

* Intellectual disability * Organic disorders

Design outcomes

Primary

MeasureTime frameDescription
Stigma Stress Scale (Rüsch, Corrigan, Wassel et al., 2009; Rüsch, Corrigan, Powell et al., 2009)Change from T0 to T1 and T2 (assessed at T0 = week 0; T1 =week 3; T2 = week 6)8 items, from 1 (strongly disagree) to 7 (strongly agree)

Secondary

MeasureTime frameDescription
Satisfaction with life (Lehman, 1988)Change from T0 to T2 (assessed at T0 = week 0; T2 = week 6)1 item from Lehmans Quality of Life Scale, from 1 (very dissatisfied) to 7 (very satisfied)
The Questionnaire about the Process of Recovery - 15 (QPR-15) (Niel et al 2007)Change from T0 to T2 (assessed at T0 = week 0; T2 = week 6)15 items short version, from 0 (strongly disagree) to 4 (strongly agree)
Internalised Stigma of Mental Illness Inventory (ISMI-10) (Boyd, Otilingam, & Deforge, 2014)Change from T0 to T2 (assessed at T0 = week 0; T2 = week 6)10-item short version, from 1 (strongly disagree ) to 4 (strongly agree )
Patient Health Questionnaire-4 (PHQ-9) (Kroenke et al 2009)Change from T0 to T2 (assessed at T0 = week 0; T2 = week 6)9 items, 0 (not at all) to 3 (nearly every day)
Generalized Anxiety disorder (GAD-7) (Spitzer et al, 2006)Change from T0 to T2 (assessed at T0 = week 0; T2 = week 6)7 items, from 0 (not at all) to 3 (nearly every day)
Disclosure Distress (Rüsch et al., 2014a)Change from T0 to T2 (assessed at T0 = week 0; T2 = week 6)1 item In general, how distressed or worried are you in terms of secrecy or disclosure of your mental illness to others?, from 1 (not at all) to 7 (very much)
Warwick and Edinburgh Wellbeing Scale (WEMWBS) (Tennant et al 2007)Change from T0 to T2 (assessed at T0 = week 0; T2 = week 6)14-items, from 1 (not at all) to 5 (all the time)

Other

MeasureTime frameDescription
Acceptability of HOP program participantsAssessed after T2 = week 6Semi-structured focus-group interview about acceptability with HOP program participants
Acceptability of HOP peer facilitatorsAssessed after T2 = week 6Semi-structured focus-group interview about acceptability with HOP peer facilitators
DisclosureAssessed at T1 and T2 (T1= week 3 and T2 = week 6)Have you disclosed your mental illness the last three (or six) weeks?, YES/NO How satisfied are you with that?, from 1 (very dissatisfied) to 7 (very satisfied)
Feasibility of HOP programTracked during trial and evaluated after completion (T2 = week 6)Recruitment rates (numbers of participants in number of weeks) and drop-out rates.

Countries

Norway

Contacts

Primary ContactCarmen Simonsen, PhD
carmen.simonsen@psykologi.uio.no0047 90988741
Backup ContactSindre Hembre Kruse, BSc
sikrus@ous-hf.no0047 46440055

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026